tradmap

MMSI Earnings Merit Medical Systems Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$0 $1 $2 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $758M $2B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$10M $59M $128M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
$0 $0 $1 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $209M $419M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
$0 $21M $42M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q3 20262026-09-300.702026-10-2910-Q
Q2 20262026-06-300.652026-07-3010-Q
Q1 20262026-03-310.682026-04-3010-Q
Q4 2025 (derived)2025-12-310.642026-02-2410-K
FY 20252025-12-312.132026-02-2410-K
Q3 20252025-09-300.462025-10-3010-Q
Q2 20252025-06-300.542025-07-3010-Q
Q1 20252025-03-310.492025-04-2410-Q
Q4 2024 (derived)2024-12-310.462025-02-2510-K
FY 20242024-12-312.032025-02-2510-K
Q3 20242024-09-300.482024-10-3010-Q
Q2 20242024-06-300.612024-08-0110-Q
Q1 20242024-03-310.482024-04-3010-Q
Q4 2023 (derived)2023-12-310.472024-02-2810-K
FY 20232023-12-311.622024-02-2810-K
Q3 20232023-09-300.442023-10-2610-Q
Q2 20232023-06-300.352023-07-2810-Q
Q1 20232023-03-310.362023-04-2810-Q
Q4 2022 (derived)2022-12-310.572023-02-2410-K
FY 20222022-12-311.292023-02-2410-K
Q3 20222022-09-300.272022-10-2810-Q
Q2 20222022-06-300.272022-08-0510-Q
Q1 20222022-03-310.182022-05-0610-Q
Q4 2021 (derived)2021-12-310.352022-03-0110-K
FY 20212021-12-310.842022-03-0110-K
Q3 20212021-09-300.212021-11-0510-Q
Q2 20212021-06-300.092021-08-0610-Q
Q1 20212021-03-310.192021-05-0710-Q
Q4 20202020-12-310.272021-03-0110-K
FY 20202020-12-31-0.182021-03-0110-K
Q3 20202020-09-30-0.052020-11-0510-Q
Q2 20202020-06-30-0.342020-08-0610-Q
Q1 20202020-03-31-0.062020-05-1110-Q
Q4 20192019-12-31-0.082020-03-0210-K
FY 20192019-12-310.102020-03-0210-K
Q3 20192019-09-30-0.062019-11-0810-Q
Q2 20192019-06-300.122019-08-0910-Q
Q1 20192019-03-310.112019-05-0310-Q
Q4 20182018-12-310.162019-03-0110-K
FY 20182018-12-310.782019-03-0110-K
Q3 20182018-09-300.302018-11-0910-Q
Q2 20182018-06-300.212018-08-0910-Q
Q1 20182018-03-310.102018-05-1010-Q
Q4 20172017-12-310.132018-03-0110-K
FY 20172017-12-310.552018-03-0110-K
Q3 20172017-09-30-0.072017-11-0910-Q
Q2 20172017-06-300.192017-08-0710-Q
Q1 20172017-03-310.322017-05-1010-Q
Q4 20162016-12-310.172017-03-0110-K
FY 20162016-12-310.452017-03-0110-K
Q3 20162016-09-300.022016-11-0910-Q
Q2 20162016-06-300.162016-08-0810-Q
Q1 20162016-03-310.102016-05-0910-Q
Q4 20152015-12-310.142016-02-2910-K
FY 20152015-12-310.532016-02-2910-K
Q3 20152015-09-300.112015-11-0910-Q
Q2 20152015-06-300.172015-08-0710-Q
Q1 20152015-03-310.122015-05-1110-Q
Q4 20142014-12-310.202015-03-0510-K
FY 20142014-12-310.532015-03-0510-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.